Latest Quarter
2026-04-08
HighTide Therapeutics Inc (2511.HK)
Revenue
$0.0
Net Income
-$120K
Operating Margin
N/A
Free Cash Flow
-$303M
Debt / Assets
24.2%
Values are in USD and rounded to the nearest whole number unless noted.
Swipe horizontally to view all columns.
| Income Statement (Quarterly) | 2026-04-08 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 |
| Cost of Revenue | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 | 0 |
| Operating Expenses | ||||
| R&D Expenses | 0 | 0 | 0 | 0 |
| SG&A Expenses | 21,624 | 21,624 | 10,812 | 17,587 |
| Operating Expenses | 128,038 | 128,038 | 64,019 | 98,363 |
| Operating Income | -128,039 | -128,039 | -64,020 | -98,363 |
| Interest Expense | 0 | 0 | 0 | 0 |
| Income Before Tax | -113,851 | -113,851 | -56,926 | -85,556 |
| Income Tax Expense | 6 | 6 | 3 | 135 |
| Net Income | -120,317 | -120,317 | -60,159 | -85,422 |
| Per Share | ||||
| EPS | -0.26 | -0.26 | -0.13 | -0.19 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Statement (Annual) | 2024-12-31 | 2023-12-31 |
|---|---|---|
| Revenue | 0 | 0 |
| Cost of Revenue | 0 | 1,830,196 |
| Gross Profit | 0 | -1,830,197 |
| Operating Expenses | ||
| R&D Expenses | 0 | 0 |
| SG&A Expenses | 81,229 | 136,670,000 |
| Operating Expenses | 444,754 | 438,336,000 |
| Operating Income | -444,754 | -440,357,041 |
| Interest Expense | 0 | 400,000 |
| Income Before Tax | -381,519 | -939,230,000 |
| Income Tax Expense | 269 | 76,000 |
| Net Income | -381,788 | -939,306,000 |
| Per Share | ||
| EPS | -0.84 | -2.02 |
| EPS Diluted | 0.00 | 0.00 |
| Balance Sheet (Quarterly) | 2024-12-31 | 2023-12-31 |
|---|---|---|
| Assets | ||
| Cash and Cash Equivalents | 310,750,000 | 608,212,000 |
| Short Term Investments | 179,772,000 | 127,489,000 |
| Net Receivables | 295,000 | 0 |
| Inventory | 0 | 0 |
| Total Current Assets | 513,371,000 | 778,753,000 |
| Property Plant Equipment | 23,891,000 | 14,981,000 |
| Goodwill and Intangibles | 0 | 0 |
| Total Assets | 559,931,000 | 795,036,000 |
| Liabilities | ||
| Account Payables | 51,473,000 | 30,507,000 |
| Short Term Debt | 52,419,000 | 5,968,000 |
| Total Current Liabilities | 109,946,000 | 79,811,000 |
| Long Term Debt | 25,486,000 | 10,464,000 |
| Total Liabilities | 135,763,000 | 92,262,000 |
| Shareholders Equity | ||
| Retained Earnings | -2,078,099,000 | 636,122,272 |
| Total Shareholders Equity | 424,168,000 | 702,774,000 |
| Balance Sheet (Annual) | 2024-12-31 | 2023-12-31 |
|---|---|---|
| Assets | ||
| Cash and Cash Equivalents | 310,750,000 | 608,212,000 |
| Short Term Investments | 179,772,000 | 127,489,000 |
| Net Receivables | 295,000 | 0 |
| Inventory | 0 | 0 |
| Total Current Assets | 513,371,000 | 778,753,000 |
| Property Plant Equipment | 23,891,000 | 14,981,000 |
| Goodwill and Intangibles | 0 | 0 |
| Total Assets | 559,931,000 | 795,036,000 |
| Liabilities | ||
| Account Payables | 51,473,000 | 30,507,000 |
| Short Term Debt | 52,419,000 | 5,968,000 |
| Total Current Liabilities | 109,946,000 | 79,811,000 |
| Long Term Debt | 25,486,000 | 10,464,000 |
| Total Liabilities | 135,763,000 | 92,262,000 |
| Shareholders Equity | ||
| Retained Earnings | -2,078,099,000 | 636,122,272 |
| Total Shareholders Equity | 424,168,000 | 702,774,000 |
| Cash Flow Statement (Quarterly) | 2024-12-31 | 2023-12-31 |
|---|---|---|
| Operating Activities | ||
| Net Income | -381,788,000 | -939,230,000 |
| Depreciation & Amortization | 0 | 1,829,000 |
| Stock Based Compensation | 96,932,000 | 93,493,000 |
| Change in Working Capital | 3,939,000 | -12,781,000 |
| Operating Cash Flow | -298,466,000 | -357,919,000 |
| Investing Activities | ||
| Capital Expenditure | -4,285,000 | -801,000 |
| Investments | 0 | -801,000 |
| Investing Cash Flow | -54,660,000 | 316,658,000 |
| Financing Activities | ||
| Debt Repayment | 53,389,000 | -4,650,000 |
| Common Stock Issued/Repurchased | 0 | 252,895,000 |
| Dividends Paid | 0 | 0 |
| Financing Cash Flow | 0 | 361,103,000 |
| Summary | ||
| Free Cash Flow | -302,751,000 | -358,720,000 |
| Net Change in Cash | -297,462,000 | 335,165,000 |
| Cash Flow Statement (Annual) | 2024-12-31 | 2023-12-31 |
|---|---|---|
| Operating Activities | ||
| Net Income | -381,788,000 | -939,230,000 |
| Depreciation & Amortization | 0 | 1,829,000 |
| Stock Based Compensation | 96,932,000 | 93,493,000 |
| Change in Working Capital | 3,939,000 | -12,781,000 |
| Operating Cash Flow | -298,466,000 | -357,919,000 |
| Investing Activities | ||
| Capital Expenditure | -4,285,000 | -801,000 |
| Investments | 0 | -801,000 |
| Investing Cash Flow | -54,660,000 | 316,658,000 |
| Financing Activities | ||
| Debt Repayment | 53,389,000 | -4,650,000 |
| Common Stock Issued/Repurchased | 0 | 252,895,000 |
| Dividends Paid | 0 | 0 |
| Financing Cash Flow | 0 | 361,103,000 |
| Summary | ||
| Free Cash Flow | -302,751,000 | -358,720,000 |
| Net Change in Cash | -297,462,000 | 335,165,000 |